Asia-Pacific Market For Carbapenem-Resistant Enterobacteriaceae Testing Is Expected To Expand During 2022-2032

Market Overview

Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.

Get a sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2268

Carbapenem-resistant Enterobacteriaceae Testing Market: Key Players

Some of major participants operating in the Carbapenem-resistant Enterobacteriaceae Testing market are

• TBA
• SolGent Co., Ltd.
• ELITechGroup
• ALIFAX S.r.l.
• bioMérieux, Inc.

Carbapenem-resistant Enterobacteriaceae Testing Market: Regional Outlook

According to The Centers for Disease Control and Prevention (CDC), by 2013 Carbapenem-resistant enterobacteriaceae was found in almost 42 states. CDC also stated that enterobacteriaceae proportion of Carbapenem-resistance has consistently increased and has increased four-fold in the past ten years. During the early 2000s, CRE was rare in the North America region.

However, the breakout of CRE in the northeast spread through the US, thereby boosting the market for Carbapenem-resistant enterobacteriaceae testing in the region. The Asia-pacific market for Carbapenem-resistant enterobacteriaceae testing is also expected to expand during the forecast period because of detection of different classes of carbapenemase.

Pre Book this report: https://www.factmr.com/checkout/2268

Carbapenem-resistant Enterobacteriaceae Testing Market: Segmentation

Based on test type, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:

• Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
• Minimal inhibitory concentration Carbapenem-resistant Enterobacteriaceae Testing
• Other types of Carbapenem-resistant Enterobacteriaceae Testing

Based on end users, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:

• Hospitals
• Ambulatory Surgical Centers
• Intensive Care Units
• Clinics
• Nursing Homes
• Long Term Acute Care Centers
• Others

Based on geography, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:

• North America
• Latin America
• Europe
• CIS & Russia
• Japan
• APEJ
• Middle East & Africa

Enquire before buying: https://www.factmr.com/connectus/sample?flag=EB&rep_id=2268

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

The post Asia-Pacific Market For Carbapenem-Resistant Enterobacteriaceae Testing Is Expected To Expand During 2022-2032 appeared first on Latest Market Reports.